The appointment recognizes clinical and administrative colleagues across Group Health who provide invaluable support for the organization’s research.
As patients assume their groundbreaking role in breast cancer research at KPWHRI, the national press takes notice.
For Breast Cancer Awareness Month, Dr. Diana Buist tells how Kaiser Permanente research helps women and their doctors decide if, when, and how to screen.
Group Health, Kaiser Permanente researchers in JAMA Internal Medicine
For the three million women in the United States who’ve survived breast cancer, difficult health care choices come with the territory. But even after successful treatment, an important question lingers: Should they consider magnetic resonance imaging (MRI) in addition to mammography for ongoing breast cancer screening, or “surveillance”?
A large national study in JAMA Internal Medicine has found that the rate of women receiving breast MRI (magnetic resonance imaging) nearly tripled from 2005 to 2009: from four to 11 exams per 1,000 women.
Researchers used electronic health records to identify Group Health patients who weren’t screened regularly for cancer of the colon and rectum—and to encourage them to be screened. This centralized, automated approach doubled these patients’ rates of on-time screening—and saved health costs—over two years. The March 5 Annals of Internal Medicine published the randomized controlled trial.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.